Kalypsys, Inc., (San Diego, USA) is a biopharmaceutical company pioneering an industrial approach to pathway-based drug discovery. Kalypsys implements discovery programs across a broad number of therapeutic areas using its highly automated and integrated suite of discovery technologies in biology, chemistry and informatics. By using a pathway-based discovery strategy together with these integrated technologies, Kalypsys is able to significantly improve the efficiency and productivity of drug discovery.